Hacettepe University Medical Faculty; Neurology

Ankara 06100

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, Multiple Sclerosis, Relapsing-Remitting, Paroxysmal Nocturnal Hemoglobinuria, Relapsing Multiple Sclerosis

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors — Running, not enrolling
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) — Stopped early